All Stories

  1. A retrospective analysis of the risk factors for vacuum-assisted vaginal deliveries and outcomes following mid/low cavity and perineal applications
  2. The impact of composite maternal & fetal ultrasound assessment on the mode of delivery in large-for-gestational-age fetuses: the Macrodia Trial
  3. Meningioma during pregnancy: what can influence the management? A case series and review of the literature
  4. COVID‐19‐associated coagulopathy and unfavorable obstetric outcomes in the third trimester of pregnancy
  5. Oral supplementation with arginine, willow bark, magnesium and calcium in prevention of preterm birth
  6. Reply to correspondence: Prenatal diagnosis of central nervous system abnormalities: Neurosonography versus fetal magnetic resonance imaging
  7. Reply to correspondence: Vaginal delivery in a woman infected with SARS-CoV-2 – The first case reported in Portugal
  8. A practical approach for the management of obstetric and infertile women during the phase two of the novel coronavirus disease 2019 (COVID ‐19) pandemic
  9. Proposal for radiologic diagnosis and follow-up of COVID-19 in pregnant women
  10. The novel coronavirus (2019-nCoV) in pregnancy: What we need to know
  11. Circulating Nucleic Acids in Maternal Plasma and Serum in Pregnancy Complications: Are They Really Useful in Clinical Practice? A Systematic Review
  12. Ultrasound assessment of maternal adipose tissue during 1st trimester screening for aneuploidies and risk of developing gestational diabetes
  13. Particulate Air Pollution, Blood Mitochondrial DNA Copy Number, and Telomere Length in Mothers in the First Trimester of Pregnancy: Effects on Fetal Growth
  14. ASPRE Trial
  15. ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm
  16. Influence of cryopreservation on perinatal outcome after blastocyst- vs cleavage-stage embryo transfer: systematic review and meta-analysis
  17. Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia
  18. Maternal Subcutaneous and Visceral Adipose Ultrasound Thickness in Women with Gestational Diabetes Mellitus at 24-28 Weeks' Gestation
  19. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations
  20. Sphenofrontal distance on three-dimensional ultrasound in euploid and trisomy-21 fetuses at 16-24 weeks' gestation
  21. In Estimated Good Prognosis Patients Could Unexpected “Hyporesponse” to Controlled Ovarian Stimulation be Related to Genetic Polymorphisms of FSH Receptor?
  22. Assisted conception and placental perfusion assessed by uterine artery Doppler at 11-13 weeks' gestation
  23. Contribution of Method of Conception on Pregnancy Outcome after the 11–13 Weeks Scan
  24. Multiparameter analysis of heart rate variability signal for the investigation of high risk fetuses
  25. Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin-releasing hormone agonists: Relationship between clinical features and immunohistochemical changes
  26. Prenatal Diagnosis of Ulbright-Hodes Syndrome
  27. Preoperative Treatment of Uterine Leiomyomas: Clinical Findings and Expression of Transforming Growth Factor-β3 and Connective Tissue Growth Factor
  28. Index Index